Bioavailability of Orally Administered Micronised Fluticasone Propionate

被引：0

作者：

Christine Falcoz

Ruth Oliver

Jo E. McDowall

Pietro Ventresca

Alan Bye

Peter T. Daley-Yates

机构：

[1] Glaxo Wellcome Research and Development,Clinical Pharmacology

[2] GloboMax,Experimental Medicine Office U4042

[3] Glaxo Wellcome S.p.A.,undefined

来源：

Clinical Pharmacokinetics | 2000年 / 39卷

关键词：

Allergic Rhinitis; Fluticasone Propionate; Beclomethasone Dipropionate; Absolute Oral Bioavailability; Urinary Cortisol Excretion;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：9 / 15

页数：6

共 13 条

[1]

Ventresca G.P.(1994)Absorption of oral fluticasone propionate in healthy subjects Am J Respir Crit Care Med 149 A214-1P

[2]

Mackie A.E.(1997)Phannacokinetics of fluticasone propionate inhaled from the Diskhaler® and the Diskus® powder devices in healthy subjects Br J Clin Pharmacol 43 540P-61

[3]

Moss J.A.(1993)A sensitive radioim-munoassay, incorporating solid-phase extraction, for fluticasone 17-propionate in plasma J Pharm Biomed Anal 11 557-104

[4]

Mackie A.E.(1998)Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less Respir Med 92 95-75

[5]

Falcoz C.(1995)Inhaled glucocorticoids for asthma N Engl J Med 332 868-undefined

[6]

McDowall J.E.(undefined)undefined undefined undefined undefined-undefined

[7]

Bain B.M.(undefined)undefined undefined undefined undefined-undefined

[8]

Harrison G.(undefined)undefined undefined undefined undefined-undefined

[9]

Jenkins K.D.(undefined)undefined undefined undefined undefined-undefined

[10]

Barnes N.C.(undefined)undefined undefined undefined undefined-undefined

← 1 2 →